-+ 0.00%
-+ 0.00%
-+ 0.00%

Clear Street Initiates Coverage On Cellectis with Buy Rating, Announces Price Target of $9

Benzinga·12/23/2025 10:02:57
语音播报
Clear Street analyst Bill Maughan initiates coverage on Cellectis (NASDAQ:CLLS) with a Buy rating and announces Price Target of $9.